AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets closed

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
160.41-1.63 (-1.01%)
At close: 4:00PM EDT
People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close162.04
Open162.15
Bid160.01 x 100
Ask160.40 x 100
Day's Range160.25 - 162.73
52 Week Range133.64 - 184.21
Volume2,442,140
Avg. Volume3,777,707
Market Cap118.04B
Beta1.78
PE Ratio (TTM)15.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.84%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Amgen Trumps Regeneron, Sanofi In Cholesterol Drug Sales
    Investor's Business Dailyyesterday

    Amgen Trumps Regeneron, Sanofi In Cholesterol Drug Sales

    Amgen trumped Regeneron and Sanofi this week as prescriptions of its cholesterol-cutting drug grew.

  • PR Newswireyesterday

    Amgen Announces Webcast Of 2017 First Quarter Financial Results

    THOUSAND OAKS, Calif., April 21, 2017 /PRNewswire/ -- Amgen (AMGN) today announced that it will report its first quarter financial results on Wednesday, April 26, 2017, after the close of the U.S. financial markets. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors.

  • Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?
    Zacks2 days ago

    Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?

    We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.